The FDA said bebtelovimab is no longer authorized for use because it is not expected to neutralize the omicron BQ.1 and BQ.1.1 subvariants.
Schedule an appointment
You can also contact us at 561 805 9494 or set up a scheduled an appointment
The world on one platform
LOCAL EXPERTS. WORLDWIDE ENTITIES. ONE SIMPLE, SECURE LOGIN.
